LLM Visibility Audit
A baseline for your AI answer presence
Explore the programme ↗Market focus
AI Search Strategy for MedTech & Life Sciences.
Evidence-rich information in regulated markets. Regulated information needs audience boundaries, approved evidence and a clear distinction between education, product detail and clinical decision-making. The aim is accurate retrieval, not simplified claims.
01 / Research journey
What people need
before they choose.
Regulated information needs audience boundaries, approved evidence and a clear distinction between education, product detail and clinical decision-making. The aim is accurate retrieval, not simplified claims.
We use these questions to distinguish a useful market architecture from a set of loosely related landing pages. Each question needs a clear answer owner, a credible evidence source and an appropriate next action.
Which evidence is relevant to this indication or workflow?
Map the language, source types, evidence gaps and page roles before choosing a content format.
What information belongs to an HCP versus patient audience?
Map the language, source types, evidence gaps and page roles before choosing a content format.
Which technical or clinical documents support evaluation?
Map the language, source types, evidence gaps and page roles before choosing a content format.
How should a buyer assess an organisation’s expertise?
Map the language, source types, evidence gaps and page roles before choosing a content format.
02 / Evidence model
Information that
can carry a decision.
The challenge is to make credible information useful and findable while maintaining the rigour, review and audience boundaries your market requires. Our starting point is not a keyword list. It is an inventory of what MedTech and life sciences teams can verify, what needs expert review and where an independent source adds necessary confidence.
- approved clinical and technical evidence
- indication, workflow and audience architecture
- expert review and update governance
- clear product documentation and references
Mixing audiences or flattening evidence risks both weak discovery and poor governance.
03 / Relevant programmes
Only the work
this market needs.
We do not automatically combine every service with every market. These are the programmes with a specific brief, decision context and evidence model for MedTech & Life Sciences.
AI Search Content Strategy
Content systems for high-consideration questions
Explore the programme ↗Entity Authority & Digital PR
Stronger signals beyond your own domain
Explore the programme ↗Technical GEO
Architecture, structured evidence and retrieval
Explore the programme ↗04 / Practical questions
Does GEO replace SEO in this market?
No. Strong search foundations remain essential. GEO adds a focus on how evidence, entities and useful sources support answer-led research and recommendation.
Which assets should a team prepare first?
Begin with the evidence that answers the questions above: current product, place, expert or service information; proof; ownership; and the constraints on what can be claimed.
Can every service be a separate landing page?
Only when it has a distinct market brief. Pages that repeat a generic method are kept out of the sitemap until they can offer a meaningful perspective.
How do we decide what to do first?
We combine commercial consequence, evidence availability, user risk, market maturity and technical feasibility. The first page is not always the one with the most obvious keyword; it is the one where a better answer can change a meaningful decision.